Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure
Background: SSRIs (Selective Serotonin Reuptake Inhibitors) are the most useful drugs to treat depression during pregnancy. Intrauterine exposure to SSRIs may increase the risk of growth restriction, preterm birth and neonatal complications. However, advantages in treating depression seem to exceed...
Main Authors: | Silvia Corti, Paola Pileri, Martina I. Mazzocco, Chiara Mandò, Anna F. Moscatiello, Dario Cattaneo, Stefania Cheli, Sara Baldelli, Laura Pogliani, Emilio Clementi, Irene Cetin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2019.00309/full |
Similar Items
-
LightSNiP assay is a good strategy for Pharmacogenetics Test
by: Stefania eCheli, et al.
Published: (2015-06-01) -
Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study
by: Mahmood Mahajna, et al.
Published: (2023-12-01) -
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
by: Andrea Giacomelli, et al.
Published: (2018-11-01) -
The Effect of SSRI Exposure in Pregnancy on Early Respiratory and Metabolic Adaptation in Infants Born Preterm
by: Ayala Gover, et al.
Published: (2023-03-01) -
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
by: Montrasio C, et al.
Published: (2023-07-01)